The ongoing war involving Iran has disrupted critical shipping routes and petrochemical supplies used to manufacture essential medicines this week.
Because most active pharmaceutical ingredients are derived from oil and gas, rising energy costs are hitting drug manufacturers directly. Global logistics corridors, specifically those connecting India's massive manufacturing hubs to patients in Africa and Europe, are facing severe delays and surging costs. Health organizations warn this supply shock could trigger a new wave of medical inflation while patients already struggle with a global cost-of-living crisis.
Governments are now being pressured to provide emergency relief or release national stockpiles to protect the most vulnerable patients from running out of treatment.
.Be the first to reply to this general discussion.
